Bacterial growth dynamics and PKPD relationships of rifampicin and bedaquiline in BALB/c mice.

Model parameter estimates suggest that nearly maximum killing rate is achieved against fast-growing, but not against slow-growing populations at the tested doses. Evidence of differences in drug potency for each subpopulation may facilitate the translation of preclinical findings and improve the dose rationale for antitubercular drugs in humans.